R. A. Bawa, S. Jones / Tetrahedron 60 (2004) 2765–2770
2769
4.1.5. 9-(4S-Benzyloxazolin-2-yl)anthracene 2 (from 7).
Potassium t-butoxide (1.2 gm, 10.66 mmol) was added as a
solid to a stirred solution of chloride 7 (3.12 gm, 5.31 mmol)
in THF (20 cm3). The reaction mixture was stirred for 1 h at
room temperature, filtered through short pad of silica,
eluting with EtOAc (5 cm3). Removal of solvent gave the
title compound 2 (1.28 g, 3.80 mmol, 72%).
11,12-dicarbonyl N-methylamide 16. N-Methylmaleimide
(0.611 g, 5.51 mmol) was added in one portion as a solid at
90–95 8C to a stirred solution of 9-bromoanthracene 13
(0.500 g, 1.95 mmol) in toluene (12 cm3). The resulting
mixture was left stirring for further 7 h at 90–95 8C, cooled
to room temperature and the solvent removed under
reduced pressure to give the target compound, which was
recrystallized from toluene to afford a white solid of the title
compound 16 (0.554 g, 77%), mp 228–232 8C; (Found: C,
62.0; H, 3.8; N, 3.8; Br, 21.9. C19H14BrNO2 requires C,
62.0; H, 3.8; N, 3.80; Br, 21.70%); nmax (ATR)/cm21 1776,
1690, 1456, 1426; dH (300 MHz; CDCl3) 7.82 (1H, m,
ArCH), 7.63 (1H, m, ArCH), 7.32 (1H, m, ArCH), 7.25–
7.12 (5H, m, ArCH), 4.74 (1H, d, J¼3.3 Hz, CH), 3.37 (1H,
d, J¼8.6 Hz, COCHCHCO), 3.25 (1H, dd, J¼8.6, 3.3 Hz,
COCHCH), 2.48 (3H, s, NCH3); dC (100 MHz; CDCl3)
175.3 (CvO), 173.4 (CvO), 141.0 (ArC), 140.0 (ArC),
138.1 (ArC), 136.6 (ArC), 128.0 (ArCH), 127.9 (ArCH),
127.5 (ArCH), 127.1 (ArCH), 125.8 (ArCH), 125.3 (ArCH),
124.5 (ArCH), 123.5 (ArCH), 64.6 (CBr), 53.4 (CH), 49.0
(CH), 45.1 (CH), 24.5 (NCH3); m/z (ES) 390.0117 (100%,
MþþNa; C19H14NO2Na79Br requires 390.0106); m/z (EIþ)
370 (6%), 369 [14, Mþ (81Br)], 367 [21, Mþ (79Br)], 259
(15), 258 (97, C14H881Brþ), 256 (100, C14H879Brþ), 202
(11), 177 (13), 176 (16), 101 (8).
4.1.6. 9-(4S-Benzyloxazolin-2-yl)-10-hydro-9,10-ethano-
anthracene-11R,12R-dicarbonyl N-methylamide 9 and
9-(4S-benzyloxazolin-2-yl)-10-hydro-9,10-ethanoanthra-
cene-11S,12S-dicarbonyl N-methylamide 10. 9-(4-
Benzyloxazolin-2-yl)anthracene 2 (0.500 g, 1.48 mmol)
was dissolved in dry toluene (10 cm3), the resulting solution
heated to 90–95 8C and N-methylmaleimide (0.442 g,
3.98 mmol) added. This was left at this temperature for 4
and 1/2 h, then cooled to room temperature, and the solvent
was removed under reduced pressure to afford a pale yellow
solid of the two diastereisomers 9 and 10 (50/50 by 1H NMR
spectroscopy). This mixture was purified using column
chromatography (EtOAc/petrol, 30:70) to give a 60/40
mixture of two diastereoisomers (0.279 g, 42%) as a yellow
solid; nmax (ATR)/cm21 1776, 1697, 1456, 1433, mp 101–
104 8C; [a]D¼28.0 (c 0.5, CHCl3); dH (300 MHz; CDCl3)
Diastereoisomer A, 8.28 (1H, d, J¼7.3 Hz, ArCH), 7.32–
7.26 (4H, m, ArCH), 7.23–7.02 (7H, m, ArCH), 6.84 (1H,
d, J¼7.3 Hz, ArCH), 4.81 (1H, m, CH), 4.68 (1H, m, CH),
4.47 (1H, m, CHHO), 4.26 (1H, m, CHHO), 3.76 (1H, d,
J¼8.6 Hz, CH), 3.32 (1H, dd, J¼13.8, 5.0 Hz, CH), 3.21–
3.15 (1H, m, PhCHH), 2.99–2.91 (1H, m, PhCHH), 2.40
(3H, s, CH3); Diastereoisomer B, 8.22 (1H, d, J¼7.1 Hz,
ArCH), 7.32–7.26 (4H, m, ArCH), 7.23–7.02 (7H, m,
ArCH), 6.95 (1H, d, J¼7.2 Hz, ArCH), 4.81 (1H, m, CH),
4.68 (1H, m, CH), 4.47 (1H, m, CHHO), 4.26 (1H, m,
CHHO), 3.82 (1H, d, J¼8.6 Hz, CH), 3.41 (1H, dd, J¼13.7,
5.5 Hz, CH), 3.21–3.15 (1H, m, PhCHH), 2.99–2.91 (1H,
m, PhCHH), 2.42 (3H, s, CH3); dC (75 MHz; CDCl3) 176.9
(CvO), 175.9 (CvO), 141.2 (CvN), 138.6, 138.0, 137.2,
130.1 (ArCH), 129.8 (ArCH), 129.1 (ArCH), 127.6 (ArCH),
127.5 (ArCH), 127.1 (ArCH), 127.0 (ArCH), 126.1 (ArCH),
125.1 (ArCH), 124.3 (ArCH), 123.7 (ArCH), 71.7 (Diaster-
eomer A, CH2O), 71.3 (Diastereomer B, CH2O), 69.1, 68.7,
51.3, 49.4, 49.1, 47.7, 46.4, 42.4, 42.2, 24.7 (NCH3); m/z
(ES) 449.1881 (100%, C29H25N2O3 requires 449.1865).
4.1.9. 9,10-Dihydro-9-methyl-9,10-ethanoanthracene
11,12-dicarbonyl N-methylamide 14.18 9-Methyl-
anthracene 11 (0.192 g, 1.00 mmol) was dissolved in
toluene (10 cm3) then the resulting solution was heated to
90–95 8C and N-methylmaleimide (0.111 g, 1.00 mmol)
was added in one portion as a solid. The reaction mixture
was stirred at 90–95 8C for 2 h, cooled to room temperature
and finally the solvent was removed under reduced pressure
to afford the title product 14 as a white solid in 98%
conversion as calculated from the 1H NMR spectrum, which
was recrystallized from toluene (0.247 g, 82%), mp 146–
150 8C (lit.18 267–168 8C);† dH (300 MHz; CDCl3) 7.44–
7.39 (2H, m, ArCH), 7.30–7.11 (6H, m, ArCH), 4.78 (1H,
d, J¼3.3 Hz, COCHCH), 3.28 (1H, dd, J¼3.3, 8.4 Hz,
COCHCH), 2.86 (1H, d, J¼8.4 Hz, COCHCHCO), 2.53
(3H, s, NCH3), 2.31 (3H, s, CH3); dC (75 MHz; CDCl3)
177.2 (CvO), 176.6 (CvO), 144.9 (ArC), 142.2 (ArC),
141.4 (ArC), 139.0 (ArC), 127.3 (ArCH), 127.1 (ArCH),
126.9 (2£ArCH), 125.2 (ArCH), 124.2 (ArCH), 122.5
(ArCH), 122.4 (ArCH), 51.0 (CH), 48.9 (CH), 45.9 (CH),
45.4 (C), 24.7 (NCH3), 15.7 (CH3).
4.1.7. 9,10-Dihydro-9,10-ethanoanthracene-11,12-di-
carbonyl N-methylamide 15.17 Anthracene 12 (0.178 g,
1.00 mmol) was dissolved in toluene (10 cm3), the resulting
solution heated to 90–95 8C, and N-methylmaleimide
(0.111 g, 1.00 mmol) was added in one portion. The
reaction mixture was stirred at 90–95 8C for 2 h, cooled
to room temperature and the solvent was removed under
reduced pressure to afford the title product 15 as a grey
solid, which was recrystallized from toluene (0.169 g, 59%),
mp 278–279 8C (lit.17 262–264 8C); dH (300 MHz; CDCl3)
7.40 (2H, m, ArCH), 7.27 (2H, m, ArCH), 7.20–7.12 (4H,
m, ArCH), 4.80 (2H, s, ArCH), 3.22 (2H, s, COCH), 2.52
(3H, s, CH3); dC (75 MHz; CDCl3) 177.3 (CvO), 141.8
(ArC), 138.9 (ArC), 127.4 (ArCH), 127.1 (ArCH), 125.3
(ArCH), 125.7 (ArCH), 47.4 (CH), 45.9 (CH), 24.7 (CH3).
Spectroscopic data was in agreement to that in the literature.
4.1.10. 9-(3-Benzyloxazolinoyl)anthracene dimer 8. The
title compound was obtained as a yellow solid on leaving a
toluene solution of oxazoline 2 to slowly evaporate over the
period of several weeks, mp 219–221 8C; [a]D¼26.0 (c 1,
CHCl3); nmax (film)/cm21 1651, 1476, 1454; dH (250 MHz;
CDCl3) 7.46–7.29 (11H, m, ArCH), 7.06 (4H, m, ArCH),
6.75 (5H, m, ArCH), 6.61 (4H, m, ArCH), 5.98 (2H, t,
J¼3.5 Hz, PhCH), 4.87 (2H, m, CH), 4.46 (2H, t, J¼9.0 Hz,
CHHO), 4.26 (2H, dd, J¼9.0, 7.6 Hz, 2£CHHOH), 3.25
(4H, m, PhCH2); dC (100 MHz; CDCl3) 169.3 (CvN),
142.6 (ArC), 142.1 (ArC), 142.0 (ArC), 141.9 (ArCH),
†
The reported melting point for this compound is as stated but probably
refers to 167–168 8C. No other spectroscopic data is reported for this
compound.
4.1.8. 9,10-Dihydro-9-bromo-9,10-ethanoanthracene-